Safety of ciprofloxacin in children with cystic fibrosis

Clin Pediatr (Phila). 1993 Aug;32(8):504-6. doi: 10.1177/000992289303200811.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Adolescent
  • Alkaline Phosphatase / blood
  • Child
  • Ciprofloxacin / administration & dosage
  • Ciprofloxacin / therapeutic use*
  • Cystic Fibrosis / drug therapy*
  • Drug Resistance, Microbial
  • Female
  • Follow-Up Studies
  • Humans
  • Joint Diseases / chemically induced
  • Lung Diseases / drug therapy*
  • Lung Diseases / microbiology*
  • Male
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas aeruginosa / drug effects
  • Rifampin / administration & dosage
  • Rifampin / therapeutic use
  • Safety

Substances

  • Ciprofloxacin
  • Alkaline Phosphatase
  • Rifampin